POMDOCTOR LIMITED American Depositary Shares logo

POMDOCTOR LIMITED American Depositary Shares(POM)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$17.56
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for POM

11/13/2026: POM (1-star) is currently NOT-A-BUY. Pass it for now.

PomDoctor Limited is a micro-cap digital healthcare and internet hospital company operating in China that connects patients to doctors and pharmaceutical supply chains. The company benefits from rising demand for chronic disease management and is advancing AI-enabled health solutions. However, it faces intense competition from dominant industry rivals, ongoing net losses, and high stock price volatility. The stock may suit speculative growth investors, while market participants should closely monitor its path to profitability, regulatory developments, and liquidity management.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile top-line revenue is expanding, persistent net losses make it a speculative fit for growth strategies.
Momentum investorStrong fit while signal remains positiveLow market capitalization can generate sharp short-term price swings during positive news flows.
Value investorWeak fitUnprofitable operations and volatile market valuation prevent a traditional value appeal.
Dividend investorWeak fitThe company pays no dividends and reinvests all capital into basic operations.
Low-risk investorWeak fitHigh equity volatility and regulatory risks create an elevated risk profile.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock experiences extreme price fluctuations driven by its micro-cap status and news cycles.
Valuation riskHighUncertain earnings visibility makes fundamental valuation challenging to anchor.
Competition risk (ecosystem giants like JD Health)HighWell-capitalized competitors dominate market share and customer acquisition channels.
Business qualityMedium / highAlthough digital health services address real needs, path-to-profitability metrics require validation.
Dividend incomeLow / noneNo cash distribution or yield is provided to shareholders.
Execution riskHighManagement must successfully execute its AI and data commercialization strategy while preserving liquidity.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 58.27M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 4.4M shares
Beta -
52 Weeks Range 0.06 - 5.69
Updated Date 11/14/2026
52 Weeks Range 0.06 - 5.69
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) -40.31

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Industry classification is unavailable for this snapshot.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -28.57%
Avg. Invested days 3
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
POM receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft company fundamentals, and soft analyst coverage.

Company Fundamentals

★★★★★
POM has soft overall fundamentals (2 stars), with soft financial health, soft growth momentum, and soft ownership. In FY2025 versus FY2024, solid revenue growth (+16.7%) is partially offset by negative earnings growth (-48.3%), weak cash generation (FCF margin -37.4%), weak profitability (net margin -53.2%).

Financial Health Rating

★★★★★
POM's financial health is soft, with the relatively strongest area being soft liquidity, including working-capital and asset support (WC/assets -105.2%). Profitability is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is POM's strongest growth driver at +16.7% FY2025 versus FY2024 (solid, 4 stars). By comparison, while earnings growth (-48.3%, negative) and free-cash-flow growth (-824.6%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 0.0% (soft) and 3.1% of outstanding shares are publicly tradable (soft). Insider ownership is only 0.00%, which materially reduces the ownership score.

Top 5 Institutional Investors

Citadel Advisors Llc 0.23%
UBS Group AG 0.04%
Caitong International Asset Management Co., Limited. 0.01%
SRS Capital Advisors Inc 0.01%
Steward Partners Investment Advisory, LLC 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
POM generates approximately $131 of gross profit, $-291 of operating income, and $-374 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and moderate capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
POM has a relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Internet Hospital ServicesFees and service charges derived from online medical consultations, prescription renewals, and patient management.Generates digital service income when patients interact with doctors online.
Pharmaceutical Supply ChainWholesale and retail sales of pharmaceutical products and supply chain platform operation services.Acts as a distributor and online merchant selling medications to consumers and pharmacies.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 126.01M
Price to Sales(TTM) 0.14
Enterprise Value 126.01M
Price to Sales(TTM) 0.14
Enterprise Value to Revenue 2.05
Enterprise Value to EBITDA -
Shares Outstanding 35.76M
Shares Floating 1.12M
Shares Outstanding 35.76M
Shares Floating 1.12M
Percent Insiders -
Percent Institutions 0.01

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.